tiprankstipranks
Neurocrine Biosciences (GB:0K6R)
NASDAQ:0K6R
UK Market

Neurocrine (0K6R) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Neurocrine Biosciences’s (0K6R) Moving Averages Convergence Divergence (MACD) indicator is -4.63, suggesting Neurocrine Biosciences is a Buy.
Neurocrine Biosciences’s (0K6R) 20-Day exponential moving average is 161.53, while Neurocrine Biosciences’s (0K6R) share price is $175.81, making it a Sell.
Neurocrine Biosciences’s (0K6R) 50-Day exponential moving average is 163.35, while Neurocrine Biosciences’s (0K6R) share price is $175.81, making it a Sell.

Neurocrine (0K6R) Pivot Points

Aug 24, 2026, 07:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
146.56
150.48
152.82
156.74
159.08
163.00
165.34
Fibonacci
150.48
152.87
154.35
156.74
159.13
160.61
163.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurocrine (0K6R) Moving Averages

Aug 24, 2026, 07:42 AM
Period
Simple
Exponential
MA5
154.14Sell
154.81Sell
MA10
157.03Sell
157.25Sell
MA20
164.55Sell
161.53Sell
MA50
167.19Sell
163.35Sell
MA100
156.04Sell
158.21Sell
MA200
147.35Buy
151.21Buy
Neurocrine Biosciences’s (0K6R) 10-Day exponential moving average is 157.25, while Neurocrine Biosciences’s (0K6R) share price is $175.81, making it a Sell.
Neurocrine Biosciences’s (0K6R) 100-Day exponential moving average is 158.21, while Neurocrine Biosciences’s (0K6R) share price is $175.81, making it a Sell.
Neurocrine Biosciences’s (0K6R) stock price is $175.81 and Neurocrine Biosciences’s (0K6R) 50-day simple moving average is 167.19, creating a Sell signal.
Neurocrine Biosciences’s (0K6R) stock price is $175.81 and Neurocrine Biosciences’s (0K6R) 100-day simple moving average is 156.04, creating a Sell signal.
Neurocrine Biosciences’s (0K6R) stock price is $175.81 and Neurocrine Biosciences’s (0K6R) 200-day simple moving average is 147.35, creating a Buy signal.

Neurocrine (0K6R) Technical Indicators

Aug 24, 2026, 07:42 AM
Name
Value
Implied Action
RSI (14)
35.11
Neutral
STOCH (9,6)
31.06
Neutral
STOCHRSI (14)
18.17
Buy
MACD (12,26)
-4.63
Buy
ADX (14)
20.98
Neutral
Williams %R
-76.53
Buy
CCI (14)
-85.45
Neutral
ATR (14)
7.18
-
Ultimate Oscillator
37.65
Neutral
ROC
-7.45
Sell
Neurocrine Biosciences’s (0K6R) Relative Strength Index (RSI) is 35.11, creating a Neutral signal.
Neurocrine Biosciences’s (0K6R) Trend Strength Indicator (ADX) is 20.98, creating a Neutral signal.
Neurocrine Biosciences’s (0K6R) Commodity Channel Index (CCI) is -85.45, creating a Neutral signal.
Neurocrine Biosciences’s (0K6R) Price Rate of Change (ROC) is -7.45, creating a Sell signal.

FAQ

Is 0K6R a Buy, Hold, or Sell?
Based on 0K6R’s technical indicators, 0K6R is a Sell.
    What is 0K6R’s RSI (14)?
    0K6R’s RSI (14) is 35.11, which suggests 0K6R is a Neutral.
      What is 0K6R’s MACD?
      0K6R’s MACD is -4.63, which suggests 0K6R is a Buy.
        What is 0K6R’s 5-day moving average?
        0K6R’s 5-day moving average is 154.14, which suggests 0K6R is a Sell.
          What is 0K6R’s 20-day moving average?
          0K6R 20-day moving average is 164.55, which suggests 0K6R is a Sell.
            What is 0K6R’s 50-day moving average?
            0K6R’s 50-day moving average is 167.19, which suggests 0K6R is a Sell.
              What is 0K6R’s 200-day moving average?
              0K6R’s 200-day moving average is 147.35, which suggests 0K6R is a Buy.
                What is 0K6R’s Williams % R (14)?
                0K6R’s Williams % R (14) is -76.53, which suggests 0K6R is a Buy.
                  What is 0K6R’s CCI (14)?
                  0K6R’s CCI (14) is -85.45, which suggests 0K6R is a Neutral.
                    What is the share price of Neurocrine Biosciences?